Is a complete AKTS research report available?

No complete published report is available for Aktis Oncology, Inc. (AKTS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Aktis Oncology, Inc. (AKTS)

NASDAQ: AKTS · USD

$16.8

+0.39 (+2.4%)· Recorded snapshot

Market cap	936.9M
Revenue (ttm)	10.1M
Net income (ttm)	-73.1M
EPS (ttm)	-$2.77
Shares out	55.6M
Volume	144,808

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10.1M
Net income (ttm): -73.1M
EPS (ttm): -$2.77
Market cap: 936.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0002035832
Company name	Aktis Oncology, Inc.
Country	United States
Country code	US
CUSIP number	01021M104
Earnings date	2026-11-12
Earnings time	bmo
Employees	79
Enterprise value	$430.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2020
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2026-01-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US01021M1045
Last 10-K release date	2026-03-30
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$936.9M
Market cap category	Small-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$16.85
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	AKTS
U.S. state	Massachusetts
Website	https://www.aktisoncology.com

Metric

Value

Amount currency

USD

CIK code

0002035832

Company name

Aktis Oncology, Inc.

Country

United States

Country code

CUSIP number

01021M104

Earnings date

2026-11-12

Earnings time

bmo

Employees

Enterprise value

$430.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2020

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2026-01-09

Is primary listing

Yes

Is SPAC

ISIN number

US01021M1045

Last 10-K release date

2026-03-30

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$936.9M

Market cap category

Small-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$16.85

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

AKTS

U.S. state

Massachusetts

Website

https://www.aktisoncology.com

Metric	Value
Earnings yield	-16.45%
EV/Sales	42.36x
FCF / EV yield	-19.85%
FCF yield	-9.07%
Forward EV/Sales	54.55x
Forward P/S	119.33x
P/B ratio	1.88x
P/S ratio	92.66x
Price / tangible book value	1.92x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-16.45%

EV/Sales

42.36x

FCF / EV yield

-19.85%

FCF yield

-9.07%

Forward EV/Sales

54.55x

Forward P/S

119.33x

P/B ratio

1.88x

P/S ratio

92.66x

Price / tangible book value

1.92x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Operating margin	-866.63%
Pretax margin	-727.04%
Profit per employee	$-925,823
Revenue per employee	$127,342
ROCE	-16.59%
SBC / revenue	85.71%

Metric

Value

Operating margin

-866.63%

Pretax margin

-727.04%

Profit per employee

$-925,823

Revenue per employee

$127,342

ROCE

-16.59%

SBC / revenue

85.71%

Metric	Value
EPS growth quarters	2
EPS growth years	0
Net income growth years	0
Revenue growth	576.53%
Revenue growth (Q)	111.37%
Revenue growth (QoQ)	4.87%
Revenue growth quarters	3
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth

576.53%

Revenue growth (Q)

111.37%

Revenue growth (QoQ)

4.87%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-9.3M
Depreciation and amortization	$2.8M
EBIT	$-87.2M
EBITDA	$-84.4M
EPS	$-2.77
FCF per share	$-1.52
Financing cash flow	$337M
Free cash flow	$-84.6M
Free cash flow minus SBC	$-93.2M
Gross profit	$-68.2M
Investing cash flow	$-289.4M
Net cash flow	$-27.7M
Net income	$-73.1M
Operating cash flow minus SBC	$-83.9M
Operating income	$-87.2M
Revenue	$10.1M
Stock-based compensation	$8.6M

Metric

Value

Capital expenditures

$-9.3M

Depreciation and amortization

$2.8M

EBIT

$-87.2M

EBITDA

$-84.4M

EPS

$-2.77

FCF per share

$-1.52

Financing cash flow

$337M

Free cash flow

$-84.6M

Free cash flow minus SBC

$-93.2M

Gross profit

$-68.2M

Investing cash flow

$-289.4M

Net cash flow

$-27.7M

Net income

$-73.1M

Operating cash flow minus SBC

$-83.9M

Operating income

$-87.2M

Revenue

$10.1M

Stock-based compensation

$8.6M

Metric	Value
Altman Z-Score	8.98
Book value per share	$8.76
Debt / equity	0.02
Long-term assets	$33.1M
Long-term liabilities	$40.6M
Net cash (debt)	$506.1M
Net cash / market cap	54.29%
Net cash growth	77.47%
Net debt / equity	-1.04
Piotroski F-Score	2
Property, plant and equipment	$28.2M
Shareholders' equity	$484.8M
Tangible book value	$484.8M
Tangible book value per share	$8.76
Total assets	$557.6M
Total cash	$517.3M
Total debt	$11.2M
Total liabilities	$72.8M

Metric

Value

Altman Z-Score

8.98

Book value per share

$8.76

Debt / equity

0.02

Long-term assets

$33.1M

Long-term liabilities

$40.6M

Net cash (debt)

$506.1M

Net cash / market cap

54.29%

Net cash growth

77.47%

Net debt / equity

-1.04

Piotroski F-Score

Property, plant and equipment

$28.2M

Shareholders' equity

$484.8M

Tangible book value

$484.8M

Tangible book value per share

$8.76

Total assets

$557.6M

Total cash

$517.3M

Total debt

$11.2M

Total liabilities

$72.8M

Metric	Value
Current assets	$524.5M
Current liabilities	$32.1M
Current ratio	16.33
Net working capital	$-23.4M
Quick ratio	16.17
Working capital	$492.4M

Metric

Value

Current assets

$524.5M

Current liabilities

$32.1M

Current ratio

16.33

Net working capital

$-23.4M

Quick ratio

16.17

Working capital

$492.4M

Metric	Value
Buyback yield / dilution	-3,649.41%
Dividend yield	0%
Shareholder yield	-3,649.41%

Metric

Value

Buyback yield / dilution

-3,649.41%

Dividend yield

Shareholder yield

-3,649.41%

Metric	Value
150-day SMA	$21.58
1D price change	2.4%
1M price change	-13.3%
1M total return	-13.3%
1W price change	2.59%
1W total return	2.59%
20-day SMA	$16.90
200-day SMA	$21.06
3M price change	-30.42%
3M total return	-30.42%
50-day SMA	$20.90
50-day SMA vs 200-day SMA	50under200
52-week high	$34.19
52-week high date	2026-06-30
52-week low	$14.72
52-week low date	2026-03-30
6M price change	-16.15%
6M total return	-16.15%
All-time high	$34.19
All-time high date	2026-06-30
All-time low	$14.72
All-time low date	2026-03-30
Average true range (ATR)	$0.97
Average volume	340K
Beta (1Y)	2.41
Change from 52-week high	-50.73%
Change from 52-week low	14.44%
Change from all-time high	-50.73%
Change from all-time low	14.44%
Change from open	0.33%
Day's gap	2.07%
Dollar volume	$2.4M
High price	$17.00
Low price	$16.64
Monthly RSI	0
Open price	$16.79
Position in 52-week range	56.94%
Premarket change	1.22%
Premarket close	$16.45
Premarket price	$16.65
Previous close	$16.45
Price vs 150-day SMA	-21.93%
Price vs 20-day SMA	-0.32%
Price vs 200-day SMA	-20.02%
Price vs 50-day SMA	-19.39%
Relative volume	0.43
Return from IPO open	-37.93%
Return from IPO price	-6.89%
RSI	41.86
Sharpe ratio	-0.25
Sortino ratio	-0.27
Volume	144.8K
Weekly RSI	40.64

Metric

Value

150-day SMA

$21.58

1D price change

2.4%

1M price change

-13.3%

1M total return

-13.3%

1W price change

2.59%

1W total return

2.59%

20-day SMA

$16.90

200-day SMA

$21.06

3M price change

-30.42%

3M total return

-30.42%

50-day SMA

$20.90

50-day SMA vs 200-day SMA

50under200

52-week high

$34.19

52-week high date

2026-06-30

52-week low

$14.72

52-week low date

2026-03-30

6M price change

-16.15%

6M total return

-16.15%

All-time high

$34.19

All-time high date

2026-06-30

All-time low

$14.72

All-time low date

2026-03-30

Average true range (ATR)

$0.97

Average volume

340K

Beta (1Y)

2.41

Change from 52-week high

-50.73%

Change from 52-week low

14.44%

Change from all-time high

-50.73%

Change from all-time low

14.44%

Change from open

0.33%

Day's gap

2.07%

Dollar volume

$2.4M

High price

$17.00

Low price

$16.64

Monthly RSI

Open price

$16.79

Position in 52-week range

56.94%

Premarket change

1.22%

Premarket close

$16.45

Premarket price

$16.65

Previous close

$16.45

Price vs 150-day SMA

-21.93%

Price vs 20-day SMA

-0.32%

Price vs 200-day SMA

-20.02%

Price vs 50-day SMA

-19.39%

Relative volume

0.43

Return from IPO open

-37.93%

Return from IPO price

-6.89%

RSI

41.86

Sharpe ratio

-0.25

Sortino ratio

-0.27

Volume

144.8K

Weekly RSI

40.64

Metric	Value
Float	28.6M
Float percentage	51.4%
Shares change (QoQ)	13.72%
Shares change (YoY)	3,649.41%
Shares held by insiders	0.46%
Shares held by institutions	43.35%
Shares outstanding	55.6M
Short % of float	15.09%
Short % of shares	7.76%
Short ratio	10.1 days

Metric

Value

Float

28.6M

Float percentage

51.4%

Shares change (QoQ)

13.72%

Shares change (YoY)

3,649.41%

Shares held by insiders

0.46%

Shares held by institutions

43.35%

Shares outstanding

55.6M

Short % of float

15.09%

Short % of shares

7.76%

Short ratio

10.1 days

Aktis Oncology, Inc. (AKTS)

Price

Financial snapshot

Fair-value bridge

Latest news · AKTS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AKTS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AKTS

Frequently asked questions